GCL
SABS icon

Glazer Capital LLC’s SAB Biotherapeutics SABS Stock Holding History

Glazer Capital LLC’s Portfolio SABS Stock Details SABS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-133
Closed -$13K – 849
2021
Q3 		$13K Sell
133
-53,117
-100% -$5.19M ﹤0.01% 878
2021
Q2 		$5.31M Buy
+53,250
New +$5.31M 0.08% 275